Here we quantified in situ levels of a panel of 92 key proteins for metabolism, in estrogen receptor positive (ER+) breast cancer in women, in postmenopausal women with dense or nondense breast tissue and in premenopausal women. Here, ESR1 is linked to breast carcinoma.